Chesapeake Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Buy
38
+3
+9% +$1.44K 0.01% 201
2026
Q1
$17.4K Hold
35
0.01% 209
2025
Q4
$20.5K Hold
35
0.02% 205
2025
Q3
$17.1K Hold
35
0.02% 196
2025
Q2
$14.3K Sell
35
-10
-22% -$4.18K 0.01% 192
2025
Q1
$22.5K Buy
45
+3
+7% +$1.63K 0.02% 155
2024
Q4
$21.9K Sell
42
-1
-2% -$550 0.02% 162
2024
Q3
$26.7K Buy
43
+2
+5% +$1.18K 0.02% 157
2024
Q2
$22.8K Hold
41
0.02% 158
2024
Q1
$23.9K Sell
41
-3
-7% -$1.68K 0.02% 149
2023
Q4
$23.4K Hold
44
0.02% 176
2023
Q3
$22.3K Buy
44
+5
+13% +$2.66K 0.02% 194
2023
Q2
$20.4K Hold
39
0.02% 194
2023
Q1
$22.5K Buy
+39
New +$22K 0.02% 179

Other funds holding TMO

Chesapeake Asset Management's TMO Position: Q2 2026 in Review

Chesapeake Asset Management increased its Thermo Fisher Scientific (TMO) stake by 8.6% in Q2 2026, buying an estimated $1.44K and bringing the position to 38 shares worth $19.2K. The position accounts for 0.01% of the portfolio, ranked #201.

Chesapeake Asset Management first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $26.7K in Q3 2024. 2,621 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Chesapeake Asset Management held 38 shares of Thermo Fisher Scientific worth $19.2K as of Q2 2026.
  • Chesapeake Asset Management bought 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
  • Thermo Fisher Scientific made up 0.01% of Chesapeake Asset Management's portfolio in Q2 2026, its #201 holding.
  • Chesapeake Asset Management first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Chesapeake Asset Management's Thermo Fisher Scientific position peaked at $26.7K in Q3 2024.
  • 2,621 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.